Select Medical Holdings (SEM) Revenue (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Revenue data on file, last reported at $1.4 billion in Q1 2026.

• Quarterly Revenue rose 5.05% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 billion (up 5.79% YoY) and the FY2025 annual result came in at $5.5 billion, up 5.12% from the prior year.
• Revenue climbed to $1.4 billion in Q1 2026 per SEM's latest filing, from $1.4 billion in the prior quarter.
• Across five years, Revenue topped out at $1.6 billion in Q1 2022 and bottomed at -$142.9 million in Q4 2022.
• The 5-year median for Revenue is $1.3 billion (2024), against an average of $1.3 billion.
• The widest annual swing landed in 2022, when Revenue sank 109.16%; it then soared 952.41% in 2023.
• Tracing SEM's Revenue over 5 years: stood at -$142.9 million in 2022, then soared by 952.41% to $1.2 billion in 2023, then advanced by 7.75% to $1.3 billion in 2024, then rose by 6.41% to $1.4 billion in 2025, then grew by 1.78% to $1.4 billion in 2026.
• Per Business Quant, the three latest SEM Revenue figures stand at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025).

Peer Comparison